TY  - GEN
AU  - Bohmeyer,J
AU  - Stadler,R
AU  - Kremer,A
AU  - Nashan,D
AU  - Muche,M
AU  - Gellrich,S
AU  - Luger,T
AU  - Sterry,W
TI  - Bexarotene--an alternative therapy for progressive cutaneous T-cell lymphoma? First experiences
SN  - 1610-0379
PY  - 2005///1205
KW  - Adult
KW  - Aged
KW  - Aminoquinolines
KW  - therapeutic use
KW  - Anticarcinogenic Agents
KW  - administration & dosage
KW  - Antineoplastic Agents
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Bexarotene
KW  - Combined Modality Therapy
KW  - Cyclophosphamide
KW  - Disease Progression
KW  - Doxorubicin
KW  - Female
KW  - Humans
KW  - Imiquimod
KW  - Immunosuppressive Agents
KW  - Interferons
KW  - Lymphoma, T-Cell, Cutaneous
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Staging
KW  - PUVA Therapy
KW  - Pilot Projects
KW  - Prednisone
KW  - Remission Induction
KW  - Skin
KW  - pathology
KW  - Skin Neoplasms
KW  - Tacrolimus
KW  - Tetrahydronaphthalenes
KW  - Time Factors
KW  - Treatment Outcome
KW  - Vincristine
N1  - Publication Type: Comparative Study; Evaluation Study; Journal Article
UR  - https://doi.org/10.1046/j.1439-0353.2003.03711.x
ER  -